Consultation on Streptomyces strain K61 and Its Associated End-use Product, Proposed Re evaluation Decision PRVD2019-08

Health Canada is consulting Canadians on the proposal to continue all uses of Streptomyces strain K61. Streptomyces strain K61 is a biological fungicide used in the product Mycostop Biofungicide to suppress effects such as damping-off, root and crown rot, and wilt caused by pathogenic fungi on greenhouse plants.

Following a re-evaluation by Health Canada's Pest Management Regulatory Agency, no additional risk mitigation measures are proposed to product labels. To meet current labelling standards, Health Canada proposes labels clarify that the products are for greenhouse use only as well as update statements on personal protective equipment and the restricted-entry interval.

For more information on the proposed decision open the "Proposed Re-evaluation Decision".

How to Get Involved

This consultation is open for comment from 25 July 2019 to 23 October 2019 (90 calendar days).

To comment on PRVD2019-08:

Step 1

Request the full consultation document to read the Science Evaluation that is the basis of this proposed regulatory decision.

Step 2

Submit comments to the PMRA Publications Section.

All comments received will be considered. A final re-evaluation decision will consider additional scientific information provided during the public comment period.

Please refer to the document title (for example: PRVD2019-08, Streptomyces strain K61 and Its Associated End-use Product) when providing comments.

Reporting to Canadians

Health Canada will make the results of this consultation available on this website. Once the decision is finalized, the PMRA will post a Re-evaluation Decision on the Pesticides and Pest Management Reports and Publications portion of Canada.ca.

If you have any questions, contact the Pest Management Information Service.

Interested in our other consultations? Sign up and stay informed about topics that matter to you.